Arrowstreet Capital’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $454M | Buy |
|
|||||
2025
Q1 | $331M | Buy |
|
|||||
2023
Q4 | – | Sell |
|
|||||
2023
Q3 | $862K | Sell |
|
|||||
2023
Q2 | $11.5M | Sell |
|
|||||
2023
Q1 | $115M | Buy |
|
|||||
2022
Q4 | $1.15M | Sell |
|
|||||
2022
Q3 | $6.33M | Buy |
|
|||||
2022
Q2 | – | Sell |
|
|||||
2022
Q1 | $187M | Buy |
|
|||||
2021
Q4 | $63.8M | Sell |
|
|||||
2021
Q3 | $47.5M | Buy |
|
|||||
2021
Q2 | $12.1M | Buy |
|
|||||
2021
Q1 | $3.06M | Sell |
|
|||||
2020
Q4 | $36.5M | Buy |
|
|||||
2020
Q3 | $1.74M | Sell |
|
|||||
2020
Q2 | $13.8M | Sell |
|
|||||
2020
Q1 | $109M | Buy |
|
|||||
2019
Q4 | $4.56M | Buy |
|
|||||
2019
Q3 | $2.39M | Buy |
|
|||||
2019
Q2 | – | Sell |
|
|||||
2019
Q1 | $4.57M | Buy |
|
|||||
2018
Q4 | $2.37M | Buy |
|
|||||
2018
Q1 | – | Sell |
|
|||||
2017
Q4 | $2.26M | Buy |
|
|||||
2017
Q3 | $1.45M | Buy |
|
|||||
2017
Q2 | $1.07M | Buy |
|
|||||
2016
Q3 | – | Sell |
|
|||||
2016
Q2 | $24.6M | Buy |
|
|||||
2016
Q1 | – | Sell |
|
|||||
2015
Q4 | $56.6M | Sell |
|
|||||
2015
Q3 | $68.7M | Buy |
|
|||||
2015
Q2 | $43.8M | Buy |
|
|||||
2015
Q1 | – | Sell |
|
|||||
2014
Q4 | $69.8M | Sell |
|
|||||
2014
Q3 | $189M | Buy |
|
|||||
2014
Q2 | $174M | Buy |
|
|||||
2014
Q1 | $130M | Sell |
|
|||||
2013
Q4 | $282M | Buy |
|
|||||
2013
Q3 | $257M | Buy |
|
|||||
2013
Q2 | $167M | Buy |
|